KiSS-1 gene therapy (Penn State)

N/A

Report date: 2026/01/27 10:14:08

Base Information

Drug NameKiSS-1 gene therapy (Penn State)
Drug Alias Namemelanoma gene therapy (Pennsylvania State University)metastasis gene therapy (Pennsylvania State University)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionKisspeptins receptor agonists
TargetsKisspeptins receptor
Therapy Area/IndicationsBreast NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPennsylvania State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPennsylvania State University
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A